SI c.150T>G ;(p.T50=)

Variant ID: 3-164792424-A-C

NM_001041.3(SI):c.150T>G;(p.T50=)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults.

Med (New York, N.Y.)
Toledo-Romani, María Eugenia ME; García-Carmenate, Mayra M; Verdecia-Sánchez, Leslyhana L; Pérez-Rodríguez, Suzel S; Rodriguez-González, Meybis M; Valenzuela-Silva, Carmen C; Paredes-Moreno, Beatriz B; Sanchez-Ramirez, Belinda B; González-Mugica, Raúl R; Hernández-Garcia, Tays T; Orosa-Vázquez, Ivette I; Díaz-Hernández, Marianniz M; Pérez-Guevara, María Teresa MT; Enriquez-Puertas, Juliet J; Noa-Romero, Enrique E; Palenzuela-Diaz, Ariel A; Baro-Roman, Gerardo G; Mendoza-Hernández, Ivis I; Muñoz, Yaima Y; Gómez-Maceo, Yanet Y; Santos-Vega, Bertha Leysi BL; Fernandez-Castillo, Sonsire S; Climent-Ruiz, Yanet Y; Rodríguez-Noda, Laura L; Santana-Mederos, Darielys D; García-Vega, Yanelda Y; Chen, Guang-Wu GW; Doroud, Delaram D; Biglari, Alireza A; Boggiano-Ayo, Tammy T; Valdés-Balbín, Yury Y; Rivera, Daniel G DG; García-Rivera, Dagmar D; Vérez-Bencomo, Vicente V; ,
Publication Date: 2022-11-11

Variant appearance in text: SI: T50=
PubMed Link: 35998623
Variant Present in the following documents:
  • mmc3.pdf
View BVdb publication page



Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial.

The Lancet. Microbe
Chiuppesi, Flavia F; Zaia, John A JA; Frankel, Paul H PH; Stan, Rodica R; Drake, Jennifer J; Williams, Brenda B; Acosta, Anne Marie AM; Francis, Karyn K; Taplitz, Randy A RA; Dickter, Janet K JK; Dadwal, Sanjeet S; Puing, Alfredo G AG; Nanayakkara, Deepa D DD; Ash, Patricia P; Cui, Yujie Y; Contreras, Heidi H; La Rosa, Corinna C; Tiemann, Katrin K; Park, Yoonsuh Y; Medina, Joybelle J; Iniguez, Angelina A; Zhou, Qiao Q; Karpinski, Veronica V; Johnson, Daisy D; Faircloth, Katelyn K; Kaltcheva, Teadora T; Nguyen, Jenny J; Kha, Mindy M; Nguyen, Vu H VH; Francisco, Sandra Ortega SO; Grifoni, Alba A; Wong, Angela A; Sette, Alessandro A; Wussow, Felix F; Diamond, Don J DJ
Publication Date: 2022-04

Variant appearance in text: SI: T50=
PubMed Link: 35287430
Variant Present in the following documents:
  • mmc1.pdf
View BVdb publication page



Correlates of Neutralizing/SARS-CoV-2-S1-binding Antibody Response with Adverse Effects and Immune Kinetics in BNT162b2-Vaccinated Individuals.

Medrxiv : The Preprint Server For Health Sciences
Maeda, Kenji K; Amano, Masayuki M; Uemura, Yukari Y; Tsuchiya, Kiyoto K; Matsushima, Tomoko T; Noda, Kenta K; Shimizu, Yosuke Y; Fujiwara, Asuka A; Takamatsu, Yuki Y; Ichikawa, Yasuko Y; Nishimura, Hidehiro H; Kinoshita, Mari M; Matsumoto, Shota S; Gatanaga, Hiroyuki H; Yoshimura, Kazuhisa K; Oka, Shin-Ichi SI; Mikami, Ayako A; Sugiura, Wataru W; Sato, Toshiyuki T; Yoshida, Tomokazu T; Shimada, Shinya S; Mitsuya, Hiroaki H
Publication Date: 2021-07-30

Variant appearance in text: SI: T50=
PubMed Link: 34373860
Variant Present in the following documents:
  • nihpp-2021.07.27.21261237v1.pdf
View BVdb publication page



Selective Nuclear Magnetic Resonance Experiments for Sign-Sensitive Determination of Heteronuclear Couplings: Expanding the Analysis of Crude Reaction Mixtures.

Analytical Chemistry
Dal Poggetto, Guilherme G; Soares, João Vitor JV; Tormena, Cláudio F CF
Publication Date: 2020-10-20

Variant appearance in text: SI: t50=
PubMed Link: 32924438
Variant Present in the following documents:
  • ac0c02976_si_001.pdf
View BVdb publication page